Company Info
Phone(979) 446-0027
Year Established
2018
Contacts
Martin Brenner, DVM, Ph.D.CEO & CSO
Matthew Greving
Co-Founder & CTO
Felipe Duran
CFO
Marc Banjak
General Counsel
Nick DeLong, Ph.D.
VP, Corporate Development
Mike Jenkins
VP, Operations
Company Description
RubrYc Therapeutics is a biotechnology company that integrates chemistry and computation to discover and develop antibody-based drugs with unprecedented epitope selectivity.
